Skip to content

Profound Medical PROF Ratios & Valuation

FY'25FY'24FY'23
Profitability
Gross margin70.8%+4.9pp65.9%+6.0pp59.9%
Operating margin-256.3%+53.3pp-309.6%+88.4pp-398%
Net margin-264.4%-4.0pp-260.4%+133pp-393.4%
Returns
Return on equity-67.1%-6.4pp-60.7%+6.9pp-67.6%
Return on invested capital-374.1%-92.8pp-281.3%
Efficiency
Asset turnover0.2×0.0×0.2×
Liquidity
Current ratio12.5×+2.0×10.5×+3.9×6.6×
Leverage
Debt-to-equity0.1×0.0×0.1×-0.2×0.3×
Per Share
Book value per share$2.20-9.9%$2.44+65.5%$1.47
Valuation
Market capitalization$241.65M+30.7%$225.51M+24.3%$181.4M-20.2%
Price / sales12.8×-2.8×21.1×-4.1×25.2×
Price / book4.1×-0.6×3.7×-2.1×5.8×+1.5×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Profound Medical's profit margins?
Profound Medical (PROF) runs a 71.1% gross margin and a -202.6% operating margin, with a -206.8% net margin.
Where do Profound Medical's ratios come from?
Every ratio is computed from Profound Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.